MRK · News · 20261030N

Quarterly Earnings Performance

Merck & Co., Inc. · 2026-10-30 · Importance 31 · Surprise 14 · No source text

Merck reported third-quarter 2026 non-GAAP earnings of $2.49 per share, 17.5% above the Zacks consensus estimate of $2.12. Earnings per share declined 3.5% year over year from $2.58. Revenue rose 4.7% year over year to $18.09 billion, exceeding the $17.23 billion consensus estimate by approximately 5%. Excluding foreign-exchange effects, sales increased 4%.

Key facts

• Merck's third-quarter 2026 revenues increased 4.7% year over year to $18.09 billion, exceeding the Zacks Consensus Estimate of $17.23 billion by approximately 5%. source
• Merck & Co., Inc.'s shares gained 3.8% after it reported third-quarter 2026 adjusted earnings of $2.49 per share, surpassing the Zacks Consensus Estimate of $2.12 per share. source
• Merck reported third-quarter 2026 non-GAAP earnings of $2.49 per share, 17.5% above the Zacks Consensus Estimate of $2.12 and down 3.5% year over year from $2.58 per share. source
• Excluding foreign exchange effects, Merck's third-quarter 2026 sales increased 4%. source

Impact estimates